The following is a summary of “Effect of siponimod on retinal thickness, a marker of neurodegeneration, in participants with SPMS: Findings from the EXPAND OCT substudy,” published in the January 2025 ...

People with multiple sclerosis appear to have higher rates ... People with MS often develop: vision problems movement and muscle problems changes in sensation Thyroid disease affects the butterfly ...

researchers associated 51 mutations in mitochondrial DNA with amyotrophic lateral sclerosis (ALS), an incurable degenerative neurological disorder that leads to muscle atrophy and paralysis.

The most-viewed pieces of multiple sclerosis (MS) content covered remeylination ... great potential for mitigating painful symptoms or muscle spasticity. Participants involved reported significant ...

An investigational drug for multiple sclerosis from Io Therapeutics has restored leg mobility and myelin nerve coatings in ...

Optimal management of multiple sclerosis (MS), a chronic progressive ... of MS-specific features (such as brain volume, atrophy and lesions), serial trends (such as change in lesion, burden ...

multiple sclerosis, spinal muscular atrophy and other neurological diseases often rapidly decline when their movement becomes limited. “Our study supports the notion that people who are unable ...

Accepts donations from U.K. residents with MS or other conditions, and healthy volunteers who register with the bank. Donors must have longitudinal and/or clinical/medical records. Phenotypes ...

Relapsing–remitting multiple sclerosis; SIENAX: Structural image evaluation using normalization of atrophy for cross-sectional measurement; SPMS: Secondary-progressive multiple sclerosis ...